Patiromer Sorbitex Calcium Patent Expiration

Patiromer Sorbitex Calcium is Used for lowering high levels of potassium in the blood. It was first introduced by Vifor Pharma Inc in its drug Veltassa on Oct 21, 2015.


Patiromer Sorbitex Calcium Patents

Given below is the list of patents protecting Patiromer Sorbitex Calcium, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Veltassa US10485821 Ion binding polymers and uses thereof Mar 30, 2024

(Expired)

Vifor Pharma
Veltassa US11123363 Potassium-binding agents for treating hypertension and hyperkalemia Oct 08, 2033 Vifor Pharma
Veltassa US7556799 Ion binding polymers and uses thereof Feb 27, 2025 Vifor Pharma
Veltassa US8147873 Methods and compositions for treatment of ion imbalances Jun 20, 2028 Vifor Pharma
Veltassa US8216560 Ion binding polymers and uses thereof Mar 14, 2027 Vifor Pharma
Veltassa US8282913 Ion binding polymers and uses thereof May 29, 2027 Vifor Pharma
Veltassa US8287847 Ion binding polymers and uses thereof Mar 30, 2024

(Expired)

Vifor Pharma
Veltassa US8337824 Linear polyol stabilized polyfluoroacrylate compositions May 29, 2030 Vifor Pharma
Veltassa US8475780 Ion binding polymers and uses thereof Mar 30, 2024

(Expired)

Vifor Pharma
Veltassa US8778324 Ion binding polymers and uses thereof Mar 30, 2024

(Expired)

Vifor Pharma
Veltassa US8889115 Ion binding polymers and uses thereof Mar 30, 2024

(Expired)

Vifor Pharma
Veltassa US9492476 Potassium-binding agents for treating hypertension and hyperkalemia Oct 08, 2033 Vifor Pharma
Veltassa US9925212 Potassium-binding agents for treating hypertension and hyperkalemia Oct 08, 2033 Vifor Pharma


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳